Weβre proud to share that our ApexTide site in Hangzhou (Xiasha) has been awarded an EcoVadis Silver Rating, placing us among the top 15% of companies worldwide for sustainability performance π.
At the ApexTide site, we focus on peptide and oligonucleotide development and manufacturing. The site also successfully passed its first on-site U.S. FDA inspection in 2024, further demonstrating our commitment to global quality and compliance standards.
EcoVadis is a globally recognized platform that assesses corporate sustainability across four key dimensions: environment, labor and human rights, ethics, and sustainable procurement.
We remain dedicated to integrating ESG principles across our operations, driving sustainable growth in the biopharmaceutical industry together with our employees, clients, and partners.
And remember: if your CDMO takes sustainability seriously, ask them for their EcoVadis credentials.
